All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

August 25, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-09-02-2015
Volume11
Issue 9

Cytovance Biologics Acquired by Hepalink

Author(s):

Pharmaceutical Technology Editors

Cytovance Biologics anticipates continued expansion plans following acquisition by Hepalink USA

Hepalink USA, a manufacturer of biological API, announced on Aug. 24, 2015 that it has entered into a definitive agreement to acquire Cytovance Biologics, Inc., a biopharmaceutical contract development manufacturing (CDMO) company for $205.7 million in cash and contingent payments.

The addition of Cytovance Biologics to Hepalink USA Inc. and its parent company Shenzhen Hepalink Pharmaceutical Co., Ltd. adds a biologics CDMO to the company’s US portfolio, which includes Wisconsin-based Scientific Protein Laboratories LLC.

A statement announcing the acquisition reports that Hepalink's investment will accelerate Cytovance's expansion plans, which include the addition of 5000-L and 10000-L mammalian reactors, 1000-L and 5000-L microbial fermenters, and increased analytical, process development, process characterization capabilities.

Hepalink's wholly owned US subsidiary, Hepalink USA, will acquire 100% of the equity interest of Cytovance Biologics Inc. After the acquisition, Hepalink will hold 100% of the equity interest indirectly through Hepalink USA.

The transaction is expected to close in October. Cytovance Biologics Inc. will become a fully consolidated subsidiary of Hepalink USA Inc., and Cytovance management will remain in place, as will its 178 employees in the US, according to a press statement.

Source: Cytovance Biologics

 

Articles in this issue

MettlerRX-10-Reactor-Control.jpg
Technology Allows Automated Lab Reactor Control
dolomite_reactors250.jpg
Flow Chemistry Systems Offer Options
Spectrometers Comply with FDA Electronic Signature Regulation
SFT.MicroReactor.jpg
Pressure Reactor for Small Batch Reaction Chemistry
GEA-Pony-2006A2_249087.jpg
Homogenizer Offers Continuous Operation
Mayne Pharma to Invest $65m in Manufacturing Expansion

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
Advertisement
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 19th 2025

Telstar to Showcase Integrated GMP Services at Farmaforum

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 19th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
White pills on blue background | Image Credit: © neirfy - © neirfy - stock.adobe.com
August 19th 2025

EMA Grants Orphan Designation to Rilzabrutinib for IgG4-Related Disease

Feliza Mirasol
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 19th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
AbbVie’s facility in Silicon Valley, South San Francisco, California, USA - June 7, 2023. AbbVie Inc. is an American pharmaceutical company. | Image Credit: © JHVEPhoto - stock.adobe.com
August 19th 2025

AbbVie to Invest $195 Million in US API Manufacturing

Patrick Lavery
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 19th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
Related Content
Advertisement
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 19th 2025

Telstar to Showcase Integrated GMP Services at Farmaforum

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 19th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
White pills on blue background | Image Credit: © neirfy - © neirfy - stock.adobe.com
August 19th 2025

EMA Grants Orphan Designation to Rilzabrutinib for IgG4-Related Disease

Feliza Mirasol
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 19th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
AbbVie’s facility in Silicon Valley, South San Francisco, California, USA - June 7, 2023. AbbVie Inc. is an American pharmaceutical company. | Image Credit: © JHVEPhoto - stock.adobe.com
August 19th 2025

AbbVie to Invest $195 Million in US API Manufacturing

Patrick Lavery
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 19th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.